Related Experiment Video
Updated: Jan 25, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
The Relationship of Serum Uric Acid With Neurocognitive Functions in Children and Adolescents With Mild to Moderate
Stephen R Hooper1, Jennifer Roem2, Michael F Schneider2
1Department of Health Sciences, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Insights
This study found no clear link between serum uric acid (SUA) levels and neurocognitive function in children with chronic kidney disease (CKD). However, higher SUA may offer some protection against cognitive dysfunction.
Area of Science:
- Pediatric Nephrology
- Neuropsychology
- Chronic Kidney Disease Research
Background:
- Pediatric chronic kidney disease (CKD) impacts children's neurocognitive function, even in mild cases.
- Mechanisms behind neurocognitive disruption in pediatric CKD remain unclear.
- Serum uric acid (SUA) affects adult neurocognition in CKD, but its role in children is understudied.
Purpose of the Study:
- Investigate the association between serum uric acid (SUA) levels and neurocognitive function in children with mild to moderate CKD.
- Examine the relationship between changes in SUA levels and neurocognitive outcomes.
- Address a gap in understanding SUA's impact on pediatric neurocognition.
Main Methods:
- Utilized data from 593 participants in the North American Chronic Kidney Disease in Children study.
- Assessed neurocognition through IQ, problem-solving, selective attention, and working memory tests.
- Included parent ratings of executive functions for comprehensive evaluation.
Main Results:
- No consistent associations were found between SUA levels (current or changing) and neurocognitive outcomes after statistical adjustment.
- Medium to high SUA levels showed a potential neuroprotective effect, possibly reducing the risk of cognitive dysfunction.
- Specific findings suggested a protective role for SUA in verbal and visual working memory, and attention regulation.
Conclusions:
- This study, among the first to explore SUA and neurocognition in pediatric CKD, found no clear associations.
- The results suggest a complex relationship, with potential neuroprotective roles for SUA at higher levels.
- Further research is needed to fully elucidate the role of SUA in neurocognitive outcomes in pediatric CKD.
Background:
Pediatric chronic kidney disease (CKD) is known to affect the neurocognitive functioning in children with CKD, even in those with mild to moderate CKD. What is not well understood is the underlying mechanisms involved in this disruption of neurocognitive abilities. While serum uric acid (SUA) is a known factor in the disruption of neurocognition in adults with CKD, it has not been well studied in children. The primary purpose of this study was to address this gap in the literature by examining the association between both serum SUA level and change in SUA level with selected neurocognitive functions in children and adolescents with mild to moderate CKD.
Methods:
The sample included 593 participants with mild to moderate CKD for the North American Chronic Kidney Disease in Children study. Assessment of neurocognition included measures of IQ, problem solving, selective attention, working memory, and parent ratings of executive functions.
Results:
After statistical adjustment, findings did not reveal any clear patterns of association between SUA (cross-sectionally or annualized change) and any of the neurocognitive outcomes. The significant findings that were present for both verbal and visual working memory functions suggested that medium to high levels of SUA may be exerting some neuroprotective function on lessening risk for cognitive dysfunction (i.e., attention regulation).
Conclusions:
In one of the first studies to examine SUA and neurocognition in children with mild to moderate CKD, no clear associations were uncovered.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Serum Studies: Renal Function Tests

